Masaki Kaibori Selected Research

Neoplasm Metastasis (Metastasis)

11/2023	Efficacy and safety of atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma patients with esophageal-gastric varices.
3/2022	Treatment strategy for resectable colorectal cancer liver metastases from the viewpoint of time to surgical failure.
1/2022	Neoadjuvant Chemotherapy Versus Upfront Surgery for Resectable Liver Metastases from Colorectal Cancer: a Multicenter, Propensity Score-Matched Cohort Study.
10/2021	Prognostic impact of neoadjuvant chemotherapy in patients with synchronous colorectal liver metastasis: A propensity score matching comparative study.
11/2018	Prognostic factors of hepatectomy in initially unresectable colorectal liver metastasis: Indication for conversion therapy.
7/2015	[Two Patients with Recurrence of Hepatocellular Carcinoma after Liver Resection Who Achieved Long-Term Stable Disease with Small Doses of Sorafenib Therapy].
10/2014	High survival in patients operated for small isolated liver metastases from gastric cancer: a multi-institutional study.
11/2013	[A case of advanced hepatocellular carcinoma in which complete response was achieved with multimodality therapy].
11/2012	[A case of a colon cancer patient with liver metastasis subjected to hepatectomy after achieving radiographic complete response with preoperative chemotherapy].
11/2012	[Hepatectomy for liver metastasis in malignant melanoma of ocular choroid origin-a case report].

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Masaki Kaibori Research Topics

Disease

95	Hepatocellular Carcinoma (Hepatoma) 05/2024 - 03/2003
44	Neoplasms (Cancer) 01/2024 - 07/2002
12	Fibrosis (Cirrhosis) 12/2024 - 07/2002
11	Neoplasm Metastasis (Metastasis) 11/2023 - 12/2009
11	Inflammation (Inflammations) 01/2023 - 07/2007
11	Liver Diseases (Liver Disease) 12/2022 - 07/2002
10	Liver Cirrhosis (Hepatic Cirrhosis) 07/2022 - 07/2002
10	Wounds and Injuries (Trauma) 09/2021 - 02/2008
7	Cholangiocarcinoma 01/2023 - 11/2012
6	Hypertension (High Blood Pressure) 01/2023 - 11/2010
6	Acute Liver Failure (Fulminant Hepatic Failure) 12/2022 - 02/2008
6	Infections 08/2021 - 01/2005
6	Liver Failure 11/2011 - 09/2006
5	Liver Neoplasms (Liver Cancer) 05/2024 - 01/2023
5	Reperfusion Injury 12/2022 - 02/2008
5	Carcinoma (Carcinomatosis) 09/2022 - 10/2010
5	Ischemia 10/2021 - 08/2006
4	Fatigue 01/2023 - 07/2015
4	Sepsis (Septicemia) 12/2022 - 07/2011
3	Lymphatic Metastasis 10/2023 - 04/2017
3	Thrombosis (Thrombus) 08/2023 - 11/2010
3	Diarrhea 01/2023 - 07/2015
3	Colorectal Neoplasms (Colorectal Cancer) 03/2022 - 11/2018
3	Pain (Aches) 01/2022 - 07/2015
3	Stomach Neoplasms (Stomach Cancer) 01/2019 - 10/2014
3	Chronic Hepatitis (Chronic Active Hepatitis) 01/2016 - 11/2008
2	Hemorrhage 11/2023 - 08/2022
2	Surgical Wound Infection 06/2023 - 01/2014
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2023 - 06/2020
2	Proteinuria 01/2023 - 01/2023
2	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 01/2023 - 01/2007
2	Insulin Resistance 05/2022 - 08/2013
2	Hypoxia (Hypoxemia) 01/2022 - 04/2004
2	Diabetes Mellitus 09/2021 - 07/2015
2	Necrosis 01/2020 - 01/2019
2	Obesity 01/2019 - 05/2005
2	Postoperative Pain 07/2015 - 06/2012
2	Ulcerative Colitis 09/2014 - 01/2010

Drug/Important Bio-Agent (IBA)

34	Bevacizumab (Avastin)FDA Link 05/2024 - 01/2022
34	atezolizumabIBA 05/2024 - 01/2022
16	lenvatinibIBA 03/2024 - 12/2021
12	AlbuminsIBA 05/2024 - 11/2008
10	Indocyanine Green (Cardio-Green)FDA LinkGeneric 01/2024 - 03/2003
10	Sorafenib (BAY 43-9006)FDA Link 01/2023 - 11/2010
9	BilirubinIBA 05/2024 - 11/2010
9	Proteins (Proteins, Gene)FDA Link 01/2023 - 08/2006
9	CytokinesIBA 12/2022 - 07/2002
8	alpha-Fetoproteins (alpha-Fetoprotein)IBA 11/2023 - 07/2004
8	Biomarkers (Surrogate Marker)IBA 05/2023 - 09/2014
8	Messenger RNA (mRNA)IBA 01/2022 - 08/2006
7	Fetal Proteins (Fetoprotein)IBA 05/2024 - 10/2022
6	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2019 - 07/2002
5	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2024 - 01/2017
5	Serum AlbuminIBA 10/2023 - 02/2013
5	acarboxyprothrombin (PIVKA)IBA 08/2023 - 07/2004
5	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 11/2010
5	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2020 - 08/2006
4	AcidsIBA 06/2020 - 06/2014
4	Vitamin K FDA Link 10/2010 - 04/2007
3	Anti-Bacterial Agents (Antibiotics)IBA 08/2023 - 01/2014
3	NF-kappa B (NF-kB)IBA 10/2019 - 02/2008
3	EdaravoneIBA 12/2008 - 01/2005
2	Photosensitizing Agents (Photosensitizers)IBA 01/2024 - 09/2022
2	Liposomes (Liposome)IBA 01/2024 - 06/2022
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2023 - 01/2022
2	Tumor Biomarkers (Tumor Markers)IBA 08/2023 - 11/2012
2	Indicators and Reagents (Reagents)IBA 01/2023 - 01/2023
2	C-Reactive ProteinIBA 01/2023 - 10/2022
2	Simendan (Levosimendan)IBA 12/2022 - 01/2019
2	RNA (Ribonucleic Acid)IBA 09/2022 - 01/2022
2	HydrogenIBA 06/2022 - 10/2021
2	Type 2 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 2)IBA 11/2021 - 05/2021
2	Active Hexose Correlated CompoundIBA 11/2019 - 08/2014
2	ChemokinesIBA 10/2019 - 03/2008
2	Antineoplastic Agents (Antineoplastics)IBA 09/2019 - 01/2017
2	Therapeutic UsesIBA 09/2019 - 01/2010
2	Interleukin-6 (Interleukin 6)IBA 01/2019 - 09/2005
2	InterleukinsIBA 01/2019 - 08/2006
2	OligonucleotidesIBA 01/2018 - 04/2013
2	Fluvastatin FDA Link 09/2014 - 07/2013

Therapy/Procedure

45	Hepatectomy 10/2023 - 07/2002
27	Therapeutics 12/2024 - 07/2002
12	Drug Therapy (Chemotherapy) 06/2022 - 11/2010
7	Liver Transplantation 12/2024 - 05/2005
5	Photochemotherapy (Photodynamic Therapy) 01/2024 - 01/2017
5	Blood Transfusion (Blood Transfusions) 01/2018 - 04/2007
4	Segmental Mastectomy (Lumpectomy) 07/2022 - 11/2012
4	Neoadjuvant Therapy 01/2022 - 12/2009
4	Kampo Medicine (Kampo) 01/2020 - 01/2012
4	Gastrectomy 01/2019 - 10/2014
3	Aftercare (After-Treatment) 06/2022 - 01/2016
3	Sutures (Suture) 01/2022 - 08/2016
3	Adjuvant Chemotherapy 01/2022 - 07/2007
3	Length of Stay 01/2015 - 01/2014
2	Catheters 10/2023 - 06/2014
2	Oral Administration 01/2023 - 09/2014
2	Respiratory Therapy (Therapy, Respiratory) 06/2022 - 10/2021
2	Exercise Therapy (Therapy, Exercise) 05/2022 - 08/2013
2	Transplantation 11/2019 - 11/2006
2	Radiofrequency Ablation 01/2016 - 07/2015